MA22381A1 - Procede de production de vaccins - Google Patents

Procede de production de vaccins

Info

Publication number
MA22381A1
MA22381A1 MA22665A MA22665A MA22381A1 MA 22381 A1 MA22381 A1 MA 22381A1 MA 22665 A MA22665 A MA 22665A MA 22665 A MA22665 A MA 22665A MA 22381 A1 MA22381 A1 MA 22381A1
Authority
MA
Morocco
Prior art keywords
vaccines
production
Prior art date
Application number
MA22665A
Other languages
English (en)
French (fr)
Inventor
Slaoui M
Francotte M
V Wijnendale F
Bruck C
Kummert S
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of MA22381A1 publication Critical patent/MA22381A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA22665A 1991-03-21 1991-12-30 Procede de production de vaccins MA22381A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines

Publications (1)

Publication Number Publication Date
MA22381A1 true MA22381A1 (fr) 1992-07-01

Family

ID=10691984

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22665A MA22381A1 (fr) 1991-03-21 1991-12-30 Procede de production de vaccins

Country Status (12)

Country Link
CN (1) CN1064891A (hu)
AP (1) AP368A (hu)
BR (1) BR9107294A (hu)
CZ (1) CZ195793A3 (hu)
FI (1) FI934133A0 (hu)
GB (1) GB9106048D0 (hu)
HU (2) HUT67011A (hu)
IL (1) IL99899A0 (hu)
MA (1) MA22381A1 (hu)
SK (1) SK82593A3 (hu)
WO (1) WO1992016556A1 (hu)
YU (1) YU174491A (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
ATE204762T1 (de) * 1993-03-23 2001-09-15 Smithkline Beecham Biolog 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CN1304580C (zh) * 2004-07-09 2007-03-14 楼伟 重组表达人获得性免疫缺陷病毒I型的表面糖蛋白gp160
ATE493437T1 (de) * 2004-07-23 2011-01-15 Novartis Vaccines & Diagnostic Polypeptide für die oligomerisierung von antigenen
KR101505496B1 (ko) 2004-09-22 2015-03-25 글락소스미스클라인 바이오로지칼즈 에스.에이. 스태필로코쿠스에 대한 예방접종에 사용하기 위한 면역원성 조성물
DK2447719T3 (en) 2007-02-26 2016-10-10 Oxford Biotherapeutics Ltd proteins
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
WO2010084408A2 (en) 2009-01-21 2010-07-29 Oxford Biotherapeutics Ltd. Pta089 protein
WO2011054007A1 (en) 2009-11-02 2011-05-05 Oxford Biotherapeutics Ltd. Ror1 as therapeutic and diagnostic target
WO2013001369A2 (en) 2011-06-28 2013-01-03 Oxford Biotherapeutics Ltd. Therapeutic and diagnostic target
GB201213364D0 (en) 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
US20180071380A1 (en) 2015-03-20 2018-03-15 The Regents Of The University Of Michigan Immunogenic compositions for use in vaccination against bordetella
ES2929054T3 (es) 2016-05-16 2022-11-24 Access To Advanced Health Inst Formulación que contiene un agonista de TLR y métodos de uso
MX2018013640A (es) 2016-05-16 2019-08-01 Infectious Disease Res Inst Liposomas pegiladas y metodos de uso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein

Also Published As

Publication number Publication date
HUT67011A (en) 1995-01-30
CN1064891A (zh) 1992-09-30
YU174491A (sh) 1994-06-10
HU9302642D0 (en) 1994-01-28
WO1992016556A1 (en) 1992-10-01
FI934133A (fi) 1993-09-21
GB9106048D0 (en) 1991-05-08
SK82593A3 (en) 1994-01-12
BR9107294A (pt) 1994-06-14
AP9100332A0 (en) 1992-01-31
AP368A (en) 1994-10-28
FI934133A0 (fi) 1993-09-21
CZ195793A3 (en) 1994-05-18
IL99899A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
MA22471A1 (fr) Procede de production de vaccin
MA22911A1 (fr) Procede de production de formulations de vaccins.
MA22381A1 (fr) Procede de production de vaccins
MA22563A1 (fr) Procede de preparation de derives de tetrahydrocarbazole
MA22539A1 (fr) Procede de preparation de derives de quinuclidine
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
FR2541116B1 (fr) Procede pour la preparation de vaccins polyvalents (tetanos, diphterie, coqueluche) adsorbes lyophilises
FR2634194B1 (fr) Procede de production d'alumines boehmitiques
MX9206450A (es) Proceso para la produccion de isoleucina-l.
HU913664D0 (en) Process for the production of indian- and kinoline derivatives
MA23395A1 (fr) Procede de preparation de nouvelles formulations
HU913595D0 (en) Process for the production of tnf-muteines
HU9201929D0 (en) Process for the production of imidazo-diazepines
HU912005D0 (en) Process for the production of aminobenzodiazepines
HUT65728A (en) Improved process for the production of glycosil-transpherases
MC1982A1 (fr) Procede de preparation de derives de la didesoxycitidine
FR2664274B1 (fr) Procede de preparation de sulfates cycliques.
HU901852D0 (en) Process for the production of coccidiosis vaccine
HU913290D0 (en) Process for the production of cyuclodextrines
HU910151D0 (en) Process for the production of substituted 2-chloride-pyridines
HU9200933D0 (en) Process for the production of kinoline derivatives
ITMI920134A0 (it) Procedimento migliorato per la produzione di calcourea
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
EP0464582A3 (en) Process for the purification of riboflavin obtained by fermentation
HU910937D0 (en) Process for the production of 8-sulfamylethylene-2-amino-tetraline derivatives